跳至主要内容
临床试验/JPRN-UMIN000002530
JPRN-UMIN000002530已完成未知

Targeted radiotherapy for chemotherapy resistant neuroblastoma with I-131 metaiodobenzylguanidine (MIBG) - Targeted radiotherapy for chemotherapy resistant neuroblastoma with MIBG

Kanazawa University Hospital0 个研究点目标入组 90 人开始时间: 2009年9月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)patients with disturbed consciousness 2)expected life span less than 1 month 3)limited bone marrow capacity Hb<9.0, WBC count<3,000, platelet count <100,000 4)renal disorder GFR<30 ml/min/1.73 m2 5)risks for the central nerve system during treatment 6)in case that radiation safety cannot be secured. in case with uncontrolled symptoms that may require emergent medical cares. in case that understanding and cooperation cannot be obtained from family members. 7) when medical staff determine that treatment cannot be properly carried out.

研究者

相似试验